Myomo, Inc., the manufacturer of wearable medical robotics that increases functionality for people with neurological conditions and paralysis of the upper limbs, reports that new research evaluating the advantages of the MyoPro myoelectric orthosis it manufactures has discovered "statistically significant improvements" in a number of motor function measurements.
B-Temia announced that the United States Food and Drug Administration has granted 510(k) clearance for their powered human mobility device Keeogo Dermoskeleton System. The greatest medical equipment market in the world is now open thanks to this clearance.
Author Credits: Abhishek Verma, Hetal Singh
Report ID: 5103
Published Date: Jul 24, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are growing prevalence of emergency situation, rise in use of robotic exoskeleton for industrial use, and surge in preference for this product by military.
The market size of robotic exoskeleton is anticipated to attain a CAGR of ~24% over the forecast period, i.e., 2023 – 2035.
The major players in the market are Myomo, Inc., Bionik, ATOUN Inc., Cyberdyne Inc., and others.
The powered segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.